Caribou Biosciences, Inc.

CRBU

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001619856

SEC filings (opens in a new tab)

No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Caribou Biosciences, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of CRBU: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	104	1	120	+17
Shares	34.1M	4.85K	37.3M	+3.24M (+9.5%)
Value	$313.2M	$45.0K	$203.0M	−$110.1M (−35.2%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Caribou Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CRBU in Q2 2022
Institution	Shares	Value	% of portfolio
Assenagon Asset Management S.A.	1,109,929	$6.03M	0.03%
Franchise Capital Ltd	123,436	$670.0K	0.22%
Long Focus Capital Management, LLC	80,000	$434.0K	0.09%
Bellevue Group AG	70,300	$382.0K	0.01%
ExodusPoint Capital Management, LP	54,344	$295.0K	0.00%
HRT Financial LP	50,650	$275.0K	0.00%
Verition Fund Management LLC	47,489	$258.0K	0.01%
Squarepoint Ops LLC	40,171	$218.0K	0.00%
Alliancebernstein L.P.	25,100	$136.0K	0.00%
Dynamic Technology Lab Private Ltd	24,995	$136.0K	0.02%
DekaBank Deutsche Girozentrale	24,200	$135.0K	0.00%
Bailard, Inc.	23,500	$128.0K	0.01%
Voya Investment Management LLC	20,238	$110.0K	0.00%
Janney Montgomery Scott LLC	18,793	$107.0K	0.00%
Virtu Financial LLC	18,695	$102.0K	0.01%
Commonwealth Equity Services, LLC	16,240	$88.0K	0.00%
SG Americas Securities, LLC	15,347	$83.0K	0.00%
Atom Investors LP	14,844	$81.0K	0.04%
Arizona State Retirement System	13,152	$71.0K	0.00%
Pinnacle Associates Ltd	12,903	$70.0K	0.00%
Pinnacle Wealth Management Advisory Group, LLC	12,903	$70.0K	0.01%
Zurcher Kantonalbank (Zurich Cantonalbank)	10,485	$57.0K	0.00%
Cutler Group LP	5,053	$27.0K	0.00%
National Bank of Canada	3,500	$19.0K	0.00%
Group One Trading, L.P.	2,700	$15.0K	0.00%
Nisa Investment Advisors, LLC	1,780	$10.0K	0.00%
US Bancorp	1,223	$7.00K	0.00%
Castle Wealth Management LLC	500	$3.00K	0.00%
Itau Unibanco Holding S.A.	99	$1.00K	0.00%
Sargent Bickham Lagudis LLC	162	$1.00K	0.00%
International Biotechnology Trust PLC	1,378	–	–

Sold out (14)

Institutions that held Caribou Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CRBU in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Monashee Investment Management LLC	470,000	$4.32M
Laurion Capital Management LP	101,600	$933.0K
EcoR1 Capital, LLC	75,000	$689.0K
Two Sigma Investments, LP	24,456	$225.0K
Jump Financial, LLC	16,400	$151.0K
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	15,652	$144.0K
Trexquant Investment LP	13,981	$128.0K
Balyasny Asset Management LLC	11,812	$108.0K
Allspring Global Investments Holdings, LLC	8,043	$73.0K
STRS Ohio	4,400	$40.0K
Point72 Hong Kong Ltd	2,063	$19.0K
Herold Advisors, Inc.	1,750	$16.1K
FinTrust Capital Advisors, LLC	100	$1.00K
State of Wyoming	34	$0

Not filed for Q2 2022 yet (1)

Institutions that held Caribou Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBU in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Amalgamated Financial Corp.	4,851	$45.0K